-
Mornington Osteopathy
1/340 Main Street
Mornington 3931
t: 0359758782 -
Simon Clement, Osteopath
"For over twenty years we've offered comprehensive osteopathic treatment for a wide range of joint and muscle symptoms.
Patients on the Mornington Peninsula are assured of professional treatment from our qualified and caring osteopaths. Have a look around the site and learn a little about us, the practice and osteopathy and please get in contact if you have any questions. We look forward to hearing from you."
-
Monday 8:00 - 7:00 Tuesday 8:00 - 7:00 Wednesday 8:00 - 7:00 Thursday 8:00 - 7:00 Friday 8:00 - 7:00 Saturday 8:00 - 12:00 -
WorkCover, TAC and Veterans Affairs patients are eligible for osteopathic treatment. Patients may also be covered for osteopathic treatment under an Extended Care Plan (ECP) which means up to five treatments could be subsidised by Medicare. Speak to your doctor to see if you're eligible.
-

Looking for Mornington Osteopathy?
You'll find the practice and the same practitioners
in the existing location under a new name:
Renew Osteopathy Mornington
We look forward to seeing you there!
1/340 Main Street, Mornington 3931. Tel: 03 59758782
You'll find the practice and the same practitioners
in the existing location under a new name:
Renew Osteopathy Mornington
We look forward to seeing you there!
1/340 Main Street, Mornington 3931. Tel: 03 59758782
ps…
With recent public awareness initiatives prostatic cancer is something that is on a lot of people’s minds and when someone presents to us with bone pain it’s one of those things, on a long mental list, that you like to draw a line through. Many men have had a PSA test come back that seems to indicate that there might be reason for concern but recent comments and studies have shown that the PSA test should not be given as much credence as it has been to date.
In fact the creator of the blood test used to detect prostate cancer has admitted it has become a “hugely expensive public health disaster” and should be abandoned.
Richard Ablin, who developed the prostate-specific antigen test 40 years ago, used by about 1 million Australians a year yesterday agreed it had been proven inaccurate and was “hardly more effective than a coin toss”. ”PSA testing can’t detect prostate cancer, and more important, it can’t distinguish between the two types of prostate cancer – the one that will kill you and the one that won’t,” Dr Ablin wrote in a column in the The New York Times.
An American survey of 77,000 men concluded there was no decrease in the death rate in those who had yearly tests compared with those who were not offered testing. In the European trial, involving 182,000 men, it was found the death rate did decline slightly but 48 men would need to be treated to save one life.